Access to medicines

Access to medicines

One third of the world lacks  access to essential medicines.  In the poorest parts of Africa and Asia this figure rises to a half of the population. We challenge the high cost of medicines and the absence of treatment for many of the diseases affecting ou

Too often  we cannot treat patients because the medicines are too expensive, or they are no longer produced.  Sometimes, the only drugs we have are highly toxic or ineffective and nobody is looking for a better cure. 
As a medical humanitarian organisation, it is fundamentally unacceptable that access to essential medicines is increasingly difficult, particularly for the most common global infectious diseases. 

 
Access to medicines

MSF response to first regulatory approval of first oral antiviral treatment for COVID-19, molnupiravir

Press Release 4 Nov 2021
 
Access to medicines

4 reasons why Pfizer, BioNTech and Moderna must share COVID-19 mRNA vaccine technology NOW

Article 10 Sep 2021
 
Access to Healthcare

Afghanistan: Injuries and displacement soar as violence spreads around the country

Crisis Update 13 Aug 2021
 
Access to Healthcare

Libya: Recurrent violence against refugees and migrants in Tripoli detention centres forces MSF to suspend activities

Press Release 23 Jun 2021
 
Access to Healthcare

Cameroon: thousands of people continue to be denied urgent and life-saving health care as MSF’s activities in the North-West region remain suspended by the government

Press Release 22 Jun 2021
 
Access to medicines

100 years after the discovery of insulin, governments and health leaders have a crucial opportunity to support a new global resolution on diabetes and insulin access

Press Release 13 May 2021